The UK Medical Research Council are collaborating with AstraZeneca to benefit researchers of Alzheimer’s, cancer & rare disease

The Medical Research Council (MRC) has granted £7 million of funding for 15 research projects through its groundbreaking collaboration with AstraZeneca, which gave academic researchers unprecedented access to 22 chemical compounds. Scientists will use the compounds to study a broad range of conditions from common diseases like Alzheimer’s, cancer and lung disease through to rarer conditions such as motor neurone disease and muscular dystrophies.

Files

Links

http://pharmabiz.com/NewsDetails.aspx?aid=71948&sid=2

7 studenoga, 2012